BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21989430)

  • 21. Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation? A pilot study.
    Alsina AE; Makris A; Nenos V; Sucre E; Arrobas J; Franco E; Kemmer N
    Am Surg; 2014 Jul; 80(7):680-4. PubMed ID: 24987900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nonsurgical management of hepatocellular carcinoma].
    Merle P; Mornex F
    Cancer Radiother; 2010 Oct; 14(6-7):469-73. PubMed ID: 20739209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiologic complete response with sirolimus and sorafenib in a hepatocellular carcinoma patient who relapsed after orthotopic liver transplantation.
    Kim R; Aucejo F
    J Gastrointest Cancer; 2011 Mar; 42(1):50-3. PubMed ID: 20714941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
    Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multimodality treatment for hepatocellular carcinoma].
    Malek NP; Vogel A; Manns MP
    Internist (Berl); 2010 Nov; 51(11):1374-81. PubMed ID: 20938626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: the management of hepatocellular carcinoma.
    Cabrera R; Nelson DR
    Aliment Pharmacol Ther; 2010 Feb; 31(4):461-76. PubMed ID: 19925500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery.
    Famularo S; Donadon M; Cipriani F; Fazio F; Ardito F; Iaria M; Perri P; Conci S; Dominioni T; Lai Q; La Barba G; Patauner S; Molfino S; Germani P; Zimmitti G; Pinotti E; Zanello M; Fumagalli L; Ferrari C; Romano M; Delvecchio A; Valsecchi MG; Antonucci A; Piscaglia F; Farinati F; Kawaguchi Y; Hasegawa K; Memeo R; Zanus G; Griseri G; Chiarelli M; Jovine E; Zago M; Abu Hilal M; Tarchi P; Baiocchi GL; Frena A; Ercolani G; Rossi M; Maestri M; Ruzzenente A; Grazi GL; Dalla Valle R; Romano F; Giuliante F; Ferrero A; Aldrighetti L; Bernasconi DP; Torzilli G;
    JAMA Surg; 2023 Feb; 158(2):192-202. PubMed ID: 36576813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma.
    Li J; Hou Y; Cai XB; Liu B
    World J Gastroenterol; 2016 Apr; 22(15):4034-40. PubMed ID: 27099447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver Transplantation After Neoadjuvant Sorafenib Therapy: Preliminary Experience and Literature Review.
    Golse N; Radenne S; Rode A; Ducerf C; Mabrut JY; Merle P
    Exp Clin Transplant; 2018 Apr; 16(2):227-236. PubMed ID: 27212671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].
    Hoffmann K; Glimm H; Radeleff B; Richter G; Heining C; Schenkel I; Zahlten-Hinguranage A; Schirrmacher P; Schmidt J; Büchler MW; Jaeger D; von Kalle C; Schemmer P
    BMC Cancer; 2008 Nov; 8():349. PubMed ID: 19036146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
    World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical Considerations of Real Life of Hepatocellular Carcinoma in a Tertiary Center of Brazil.
    Almeida-Carvalho SR; Gomes-Ferraz ML; Loureiro-Matos CA; Benedito-Silva AT; Carvalho-Filho RJ; Renato-Perez R; Miziara-Gonzalez A; Salzedas-Netto AA; Szejnfeld D; D'Ippolito G; Pereira-Lanzoni V; Souza-Silva I
    Ann Hepatol; 2017; 16(2):255-262. PubMed ID: 28233747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodal approaches to the treatment of hepatocellular carcinoma.
    Cabibbo G; Latteri F; Antonucci M; Craxì A
    Nat Clin Pract Gastroenterol Hepatol; 2009 Mar; 6(3):159-69. PubMed ID: 19190599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?
    Vagefi PA; Hirose R
    J Gastrointest Cancer; 2010 Dec; 41(4):217-20. PubMed ID: 20443078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.
    Schwarz RE; Abou-Alfa GK; Geschwind JF; Krishnan S; Salem R; Venook AP; ; ;
    HPB (Oxford); 2010 Jun; 12(5):313-20. PubMed ID: 20590905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies.
    Matsuda Y; Ichida T; Fukumoto M
    Med Mol Morphol; 2011 Sep; 44(3):117-24. PubMed ID: 21922382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apparent remission of a solitary metastatic pulmonary lesion in a liver transplant recipient treated with sorafenib.
    Yeganeh M; Finn RS; Saab S
    Am J Transplant; 2009 Dec; 9(12):2851-4. PubMed ID: 20021481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
    Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
    World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted therapies: Role of sorafenib in HCC patients with compromised liver function.
    Di Maio M; Daniele B; Perrone F
    Nat Rev Clin Oncol; 2009 Sep; 6(9):505-6. PubMed ID: 19707242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.